Suvretta Capital Management, LLC Baxter International Inc Transaction History

Suvretta Capital Management, LLC

  • $2.54 Billion
  • Q3 2024

A detailed history of Suvretta Capital Management, LLC transactions in Baxter International Inc stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 7,970 shares of BAX stock, worth $235,752. This represents 0.01% of its overall portfolio holdings.

Number of Shares
7,970
Previous 7,970 -0.0%
Holding current value
$235,752
Previous $266,000 13.53%
% of portfolio
0.01%
Previous 0.01%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$37.88 - $43.77 $301,903 - $348,846
7,970 New
7,970 $340,000
Q3 2020

Nov 16, 2020
SELL
$78.33 - $90.73 $94.3 Million - $109 Million
-1,204,204 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$78.66 - $94.14 $94.7 Million - $113 Million
1,204,204 New
1,204,204 $104 Million
Q1 2020

May 15, 2020
SELL
$71.57 - $93.3 $90.1 Million - $118 Million
-1,259,570 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$76.7 - $88.45 $96.6 Million - $111 Million
1,259,570 New
1,259,570 $105 Million
Q4 2018

Feb 14, 2019
SELL
$61.45 - $77.8 $190 Million - $240 Million
-3,086,770 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$70.71 - $77.75 $24 Million - $26.4 Million
339,709 Added 12.37%
3,086,770 $238 Million
Q2 2018

Aug 14, 2018
BUY
$63.43 - $75.41 $174 Million - $207 Million
2,747,061 New
2,747,061 $203 Million

Others Institutions Holding BAX

# of Institutions
1,005
Shares Held
451M
Call Options Held
2.79M
Put Options Held
2.44M
View Full List

About BAXTER INTERNATIONAL INC

BAX Quotes by TradingView
  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $14.9B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Suvretta Capital Management, LLC Portfolio

Follow Suvretta Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Suvretta Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email